newsSanofi’s first mRNA COVID-19 vaccine displayed neutralising antibody seroconversion in…
28 September 2021 | By Anna Begley (European Pharmaceutical Review)
Sanofi’s first mRNA COVID-19 vaccine displayed neutralising antibody seroconversion in 91 to 100 percent of participants in a Phase I/II study.